Pathobiology and Genetics of Neural Tube Defects
Version of Record online: 9 JUN 2003
Volume 44, Issue Supplement s3, pages 14–23, June 2003
How to Cite
Finnell, R. H., Gould, A. and Spiegelstein, O. (2003), Pathobiology and Genetics of Neural Tube Defects. Epilepsia, 44: 14–23. doi: 10.1046/j.1528-1157.44.s3.5.x
- Issue online: 9 JUN 2003
- Version of Record online: 9 JUN 2003
- Birth defects;
- Spina bifida;
- Anticonvulsant drugs
Summary: Purpose: Neural tube defects (NTDs), including spina bifida and anencephaly, are common congenital malformations that occur when the neural tube fails to achieve proper closure during early embryogenesis. Based on epidemiological and clinical data obtained over the last few decades, it is apparent that these multifactorial defects have a significant genetic component to their etiology that interacts with specific environmental risk factors. The purpose of this review article is to synthesize the existing literature on the genetic factors contributing to NTD risk.
Results: To date, there is evidence that closure of the mammalian neural tube initiates and fuses intermittently at four discrete locations. Disruption of this process at any of these four sites may lead to an NTD, possibly arising through closure site–specific genetic mechanisms. Candidate genes involved in neural tube closure include genes of the folate metabolic pathway, as well as those involved in folate transport.
Conclusions: Although extensive efforts have focused on elucidating the genetic risk factors contributing to the etiology of NTDs, the population burden for these malformations remains unknown. One group at high risk for having children with NTDs is epileptic women receiving antiepileptic medications during pregnancy. Efforts to better understand the genetic factors that may contribute to their heightened risk, as well as the pathogenesis of neural tube closure defects, are reviewed herein.